Product Code: ETC8850444 | Publication Date: Sep 2024 | Updated Date: Apr 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | Author: Ravi Bhandari | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The remdesivir market in the Philippines is influenced by the ongoing global health challenges and the demand for effective treatments against COVID-19 and other viral infections. As one of the antiviral drugs used in the treatment of severe COVID-19 cases, remdesivir has seen increased demand in hospitals and healthcare settings. The Philippines` government has played an essential role in ensuring the availability of remdesivir, especially during periods of health crises, and the market is likely to remain crucial for managing infectious diseases.
The remdesivir market in the Philippines is experiencing growth due to its role in treating COVID-19 and other viral infections. Remdesivir is an antiviral medication that has gained global attention for its potential to treat severe cases of COVID-19, and it is being widely used in hospitals across the country. The ongoing demand for effective treatments for viral infections, combined with the Philippines focus on combating the pandemic, continues to drive the remdesivir market. As new treatments emerge, the market may evolve, but remdesivir remains an essential drug in managing viral diseases.
The remdesivir market has experienced fluctuating demand post-pandemic, with challenges centered on price controls, local production capabilities, and regulatory constraints. As COVID-19 subsides, demand has declined, and oversupply issues persist.
Although its use surged during the pandemic, remdesivir remains relevant for certain viral infections. Investment opportunities lie in securing distribution rights, establishing cold chain logistics, and forming alliances with hospitals and government agencies to ensure emergency stockpiling and preparedness for future outbreaks.
Remdesivir, being a treatment for viral infections such as COVID-19, falls under the regulatory scope of the Department of Health (DOH) and the Food and Drug Administration (FDA) of the Philippines. During the pandemic, the government fast-tracked the approval process and facilitated the emergency use authorization (EUA) for Remdesivir. Continued government efforts to enhance the availability of critical antiviral drugs, particularly in response to public health emergencies, sustain demand in this market.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Philippines Remdesivir Market Overview |
3.1 Philippines Country Macro Economic Indicators |
3.2 Philippines Remdesivir Market Revenues & Volume, 2021 & 2031F |
3.3 Philippines Remdesivir Market - Industry Life Cycle |
3.4 Philippines Remdesivir Market - Porter's Five Forces |
3.5 Philippines Remdesivir Market Revenues & Volume Share, By Patient Type, 2021 & 2031F |
3.6 Philippines Remdesivir Market Revenues & Volume Share, By Form, 2021 & 2031F |
4 Philippines Remdesivir Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Philippines Remdesivir Market Trends |
6 Philippines Remdesivir Market, By Types |
6.1 Philippines Remdesivir Market, By Patient Type |
6.1.1 Overview and Analysis |
6.1.2 Philippines Remdesivir Market Revenues & Volume, By Patient Type, 2021- 2031F |
6.1.3 Philippines Remdesivir Market Revenues & Volume, By Adult, 2021- 2031F |
6.1.4 Philippines Remdesivir Market Revenues & Volume, By Pediatric, 2021- 2031F |
6.1.5 Philippines Remdesivir Market Revenues & Volume, By Geriatric, 2021- 2031F |
6.2 Philippines Remdesivir Market, By Form |
6.2.1 Overview and Analysis |
6.2.2 Philippines Remdesivir Market Revenues & Volume, By Lyophilized Powder, 2021- 2031F |
6.2.3 Philippines Remdesivir Market Revenues & Volume, By Concentrated Solution, 2021- 2031F |
7 Philippines Remdesivir Market Import-Export Trade Statistics |
7.1 Philippines Remdesivir Market Export to Major Countries |
7.2 Philippines Remdesivir Market Imports from Major Countries |
8 Philippines Remdesivir Market Key Performance Indicators |
9 Philippines Remdesivir Market - Opportunity Assessment |
9.1 Philippines Remdesivir Market Opportunity Assessment, By Patient Type, 2021 & 2031F |
9.2 Philippines Remdesivir Market Opportunity Assessment, By Form, 2021 & 2031F |
10 Philippines Remdesivir Market - Competitive Landscape |
10.1 Philippines Remdesivir Market Revenue Share, By Companies, 2024 |
10.2 Philippines Remdesivir Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |